Skip to main content
QMSQMS
QMS
  • Welcome to your QMS
  • Quality Manual
  • Procedures
  • Records
  • TF_Legit.Health_Plus
    • Legit.Health Plus TF index
    • Legit.Health Plus STED
    • Legit.Health Plus description and specifications
    • R-TF-001-007 Declaration of conformity
    • GSPR
    • Clinical
      • Evaluation
      • Investigation
        • 🗄 Drafts
        • BI 2024
        • COVIDX EVCDAO 2022
        • DAO Derivación O 2022
        • DAO Derivación PH 2022
        • IDEI 2023
        • MC EVCDAO 2019
        • PH 2024
          • R-TF-015-004 Clinical investigation plan
          • R-TF-015-006 Clinical investigation report
        • SAN 2024
      • R-TF-015-008 Clinical development plan_2023_002
    • Design and development
    • Design History File (DHF)
    • IFU and label
    • Post-Market Surveillance
    • Quality control
    • Risk Management
  • Licenses and accreditations
  • External documentation
  • TF_Legit.Health_Plus
  • Clinical
  • Investigation
  • PH 2024

PH 2024

📄️ R-TF-015-004 Clinical investigation plan

Scope

📄️ R-TF-015-006 Clinical investigation report

Research Title

Previous
R-TF-015-006 Clinical investigation report
Next
R-TF-015-004 Clinical investigation plan
All the information contained in this QMS is confidential. The recipient agrees not to transmit or reproduce the information, neither by himself nor by third parties, through whichever means, without obtaining the prior written permission of Legit.Health (AI LABS GROUP S.L.)